The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools
Open accessAbstract
prediction of immune response to biothreats, emerging infectious diseases, and cancers can accelerate the design of novel and next generation vaccines and their delivery to the clinic. Over the past 20 years, vaccinologists, bioinformatics experts, and advanced programmers based in Providence, Rhode Island, USA have advanced the development of an integrated toolkit for vaccine design called iVAX, that is secure and user-accessible by internet. This integrated set of immunoinformatic tools comprises algorithms for scoring and triaging candidate antigens, selecting immunogenic and conserved T cell epitopes, re-engineering or eliminating regulatory T cell epitopes, and re-designing antigens to induce immunogenicity and protection against disease for humans and livestock. Commercial and academic applications of iVAX have included identifying immunogenic T cell epitopes in the development of a T-cell based human multi-epitope Q fever vaccine, designing novel influenza vaccines, identifying cross-conserved T cell epitopes for a malaria vaccine, and analyzing immune responses in clinical vaccine studies. Animal vaccine applications to date have included viral infections of pigs such as swine influenza A, PCV2, and African Swine Fever. "Rapid-Fire" applications for biodefense have included a demonstration project for Lassa Fever and Q fever. As recent infectious disease outbreaks underscore the significance of vaccine-driven preparedness, the integrated set of tools available on the iVAX toolkit stand ready to help vaccine developers deliver genome-derived, epitope-driven vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
Turtle, C. J., Hanafi, L.-A., Berger, C., Gooley, T. A., Cherian, S., Hudecek, M., Sommermeyer, D., Melville, K., Pender, B., Budiarto, T. M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85309 · Cited by 2,112
Reliable B cell epitope predictions: impacts of method development and improved benchmarking
Kringelum, J. V., Lundegaard, C., Lund, O., & Nielsen, M. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002829 · Cited by 697
Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
Sette, A., & Sidney, J. (1999) · Immunogenetics · doi:10.1007/s002510050594 · Cited by 635 · cited 1×
“Taken collectively, the nine HLA Class II supertype alleles, along with their respective family members, cover well-over 95% of most HLA types present in human population groups (20), and the six supertype alleles, along with their respective family members, cover over 98% of the human population groups including East…”
Background
Cited by
Cheng, J., Wang, H., & Sun, D. (2022) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12889 · Cited by 86
Yang, Y., Xue, Y., Wang, X., Wang, L., Wang, J., Zhang, J., Liu, Y., Liang, Y., & Wu, X. (2024) · Immunity, Inflammation and Disease · doi:10.1002/iid3.70074 · Cited by 2
Metadata
- Authors
- De Groot, A. S., Moise, L., Terry, F., Gutierrez, A. H., Hindocha, P., Richard, G., Hoft, D. F., Ross, T. M., Noe, A. R., Takahashi, Y., Kotraiah, V., Silk, S. E., Nielsen, C. M., Minassian, A. M., Ashfield, R., Ardito, M., Draper, S. J., & Martin, W. D.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-04-07
- Volume
- 11
- Pages
- 442-442
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3016073437
- Cited by
- 178
- References
- 3
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools. https://app.cochat.ai/papers/10.3389/fimmu.2020.00442
- The paper
- De Groot, A. S., Moise, L., Terry, F., Gutierrez, A. H., Hindocha, P., Richard, G., Hoft, D. F., Ross, T. M., Noe, A. R., Takahashi, Y., Kotraiah, V., Silk, S. E., Nielsen, C. M., Minassian, A. M., Ashfield, R., Ardito, M., Draper, S. J., & Martin, W. D. (2020). Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2020.00442
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.